Adult bone marrow-derived stem cells and the injured heart: just the beginning?

Ioannis Dimarakis1, Nagy A Habib, Myrtle Y A Gordon

  • 1Department of Surgical Oncology & Technology, Imperial College Faculty of Medicine, Imperial College of Science, Technology and Medicine, Hammersmith Hospital Campus, London W12 ONN, UK. ioannis.dimarakis@imperial.ac.uk

Insights

Cellular transplantation using adult bone marrow cells shows promise for improving heart function after myocardial ischemia. This regenerative approach offers a potential new treatment for ischemic heart disease.

Area of Science:

  • Cardiovascular Medicine
  • Regenerative Medicine
  • Cell Biology

Background:

  • Coronary artery disease is a leading cause of death, often resulting in myocardial ischemia.
  • Cellular transplantation is emerging as a potential therapeutic strategy for heart conditions.
  • Adult bone marrow-derived cells are a focus of research for myocardial repair.

Purpose of the Study:

  • To explore the potential of cellular transplantation for treating ischemic heart disease.
  • To review the current understanding of myocardial function improvement following cell therapy.
  • To highlight the implications of recent regenerative medicine research for cardiac treatment.

Main Methods:

  • Review of experimental and clinical studies on cellular transplantation for myocardial ischemia.
  • Analysis of proposed mechanisms for myocardial function improvement.
  • Synthesis of recent findings in regenerative biology relevant to heart disease.

Main Results:

  • Evidence suggests improved myocardial function in human and animal studies utilizing cellular transplantation.
  • Various theories explain the benefits of cell-based therapies for the heart.
  • Ongoing research is rapidly advancing the understanding of this treatment modality.

Conclusions:

  • Cellular transplantation, particularly with adult bone marrow cells, presents a promising avenue for treating ischemic heart disease.
  • Further understanding of regenerative information is crucial for optimizing cardiac repair strategies.
  • This field holds significant potential for improving outcomes in patients with heart conditions.

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Stem Cell Culture01:17

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
Hematopoiesis01:21

Hematopoiesis

The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...